Original Title: Optimal P2Y12 inhibitor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a network meta-analysis. Reference: Rafique AM et al. J Am Coll Cardiol Intv 2016;9:1036–46. Courtesy of Dr. Alejandro Lakowsky. Researchers drew up a network meta-analysis incorporating 37 trials with more than 88,000 patients undergoing ST elevation...
Relive SOLACI-SBHCI’16
Now, you can read the Congress coverage in this newsletter. Go back to Rio for a few minutes! JUNE 15, 2016 COVERAGE Day 1 Opening day, a tribute to Dr. José Eduardo Sousa, the first to perform a coronary catheterization in Brazil, 50 years ago. Live cases and the Cleveland Clinic Symposium, “The year of...
Percutaneous mitral valve replacement: First steps
Original Title: Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. Reference: Eleid MF et al. JACC Cardiovasc Interv. 2016 Jun 13;9(11):1161-74. Courtesy of Dr. Agustín Vecchia. Transfemoral percutaneous transvenous mitral valve implantation is a promising technique and, despite the fact that no devices...
June 10, 2016
Rio de Janeiro, June 10, 2016. Finally, a beautiful sunny day at the Wonderful City; despite this was the last day of Congress, activities went full steam ahead. In the morning, in the main room, the highlight was ACC@SOLACI – ACUTE CORONARY SYNDROMES, where Dr. Eric R. Bates and Dr. Neal Kleiman (both from USA)...
June 9, 2016
Rio de Janeiro, June 9, 2016. Another great day at Solaci/SBHCI 2016. Early this morning, the TCT/GI2@SOLACI session –Percutaneous Coronary Intervention– was conducted at Cristo Redentor room by Dr. Ajay Kirtane (USA), who talked about contemporary PCI. Following this event, Dr. Roxana Mehran (USA), delivered an excellent presentation on the evolution of stents and highlighted...
June 8, 2016
Rio de Janeiro – June 8, 2016. SOLACI-SBHCI 2016, the largest meeting on Interventional Cardiology in Latin America started with more than 1500 attendees. After the opening, by Congress President Marcelo Josén de Carvalho Cantarelli, we honored Dr. José Eduardo Sousa, the first to perform a coronary catheterization in Brazil, 50 years ago. After...
Left main PCI: Requiem for the Syntax score?
Original Title: Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity. Reference: JACC Cardiovascular Interventions. Doi: 10.1016/j.jcin.2016.02.016. Courtesy of Dr. Agustín Vecchia. In patients with unprotected left main disease (ULMD) associated to complex coronary anatomy, choosing a revascularization strategy can be challenging. Current guidelines recommend surgery for...
Low risk patients: TAVI or surgical replacement?
Original Title: Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement in Low-Risk Patients. Reference: Stefano Rosato et al. Circ Cardiovasc Interv. 2016 May;9(5):e003326. The proved efficacy of transcatheter aortic valve implantation (TAVI) in high risk patients is leading the expansion of its indication for lower risk patients. All the same, compared to the...
VII Latin American Symposium on Structural Cardiomyopathy
Do you need an update on Structural Cardiomyopathy? If so, clear your schedule from July 27 thru 29. We are hosting the 7th Latin American Symposium on Structural Cardiomyopathy, to be held at the Intercontinental Hotel in Cali, Colombia, organized by Angiografía de Occidente S.A. Featuring lectures of national and international relevance and the presence...
TriGuard: NeuroProtection Device during TAVI
Original Title: A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement. Presenter: Alexandra Lansky This work was designed to assess the safety and efficacy of the TriGuard device as a complement during transcatheter aortic valve implantation (TAVI) compared to no protection in a...